Restricted Share Options: Amounts disclosed above are per the 2023 Annual report and therefore as of 31st December 2023. Options do not have voting rights and therefore, are not included in voting shares in issue calculations.
2023 Equity financing shares: A further £1 million is due to be drawn down on or around 31st July 2024 under the “2023 Equity Financing” agreement. This will result in the issuance of an additional 20 million ordinary shares to Waterford and is expected to fund the Company’s G&A through to the end of 2024.
Total Fully Diluted Sharesare calculated as Issued Shares plus Total Restricted Share Options, plus the 2023 Equity Financing Shares.
In addition, on 17 September 2015, each of the Company’s existing Ordinary shares were subdivided into one Ordinary Share of 1 pence and one Deferred Share of 4.7142865 pence. Consequently, other than the Ordinary Shares referenced in the above table, there are in issue 121,989,500 Deferred Shares. The rights of both the Ordinary and the Deferred Shares are as set out in the Articles of Association as amended 14 September 2015 found on the Corporate Association documents page of this website
